US Stock MarketDetailed Quotes

Fulcrum Therapeutics (FULC)

Watchlist
  • 7.900
  • +0.070+0.89%
Close Apr 8 16:00 ET
  • 7.900
  • 0.0000.00%
Post 16:10 ET
526.14MMarket Cap-6.69P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fulcrum Therapeutics (FULC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
2,752.05%80M
0
0
8,990.91%80M
0
Operating revenue
--0
--0
--0
--0
--0
2,752.05%80M
--0
--0
8,990.91%80M
--0
Cost of revenue
Gross profit
Operating expense
-15.09%84.77M
16.80%22.69M
-5.22%21.86M
-27.97%19.82M
-31.61%20.4M
-12.02%99.83M
-32.69%19.43M
-18.21%23.06M
-2.36%27.51M
5.66%29.83M
Selling and administrative expenses
-21.35%28.67M
-5.69%7.28M
-10.23%7.56M
-33.37%6.83M
-30.43%7M
-12.53%36.45M
-21.78%7.72M
-15.43%8.42M
-0.74%10.25M
-12.66%10.06M
-General and administrative expense
-21.35%28.67M
-5.69%7.28M
-10.23%7.56M
-33.37%6.83M
-30.43%7M
-12.53%36.45M
-21.78%7.72M
-15.43%8.42M
-0.74%10.25M
-12.66%10.06M
Research and development costs
-11.49%56.1M
31.61%15.42M
-2.34%14.3M
-24.76%12.99M
-32.21%13.4M
-11.72%63.39M
-38.35%11.71M
-19.73%14.64M
-3.29%17.26M
18.29%19.77M
Operating profit
-327.39%-84.77M
-16.80%-22.69M
5.22%-21.86M
-137.75%-19.82M
31.61%-20.4M
82.08%-19.83M
30.59%-19.43M
15.95%-23.06M
292.33%52.49M
-6.78%-29.83M
Net non-operating interest income expense
Other net income (expense)
-2.18%9.89M
-17.55%2.36M
65.54%2.26M
-13.64%2.52M
-7.29%2.75M
-24.16%10.11M
-11.59%2.86M
-60.06%1.37M
-16.87%2.92M
-6.23%2.96M
Special income (charges)
--0
--0
--0
----
----
---2.06M
--0
---2.06M
----
----
-Less：Restructuring and merger&acquisition
--0
--0
--0
----
----
--2.06M
--0
--2.06M
----
----
Other non- operating income (expenses)
-18.76%9.89M
-17.55%2.36M
-34.02%2.26M
-13.64%2.52M
-7.29%2.75M
-8.68%12.17M
-11.59%2.86M
0.20%3.43M
-16.87%2.92M
-6.23%2.96M
Income before tax
-669.97%-74.88M
-22.73%-20.33M
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
Income tax
Net income
-669.97%-74.88M
-22.73%-20.33M
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
Net income continuous Operations
-669.97%-74.88M
-22.73%-20.33M
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
Minority interest income
Net income attributable to the parent company
-669.97%-74.88M
-22.73%-20.33M
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-669.97%-74.88M
-22.73%-20.33M
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
Basic earnings per share
-637.50%-1.18
0.00%-0.31
11.43%-0.31
-131.46%-0.28
34.88%-0.28
89.94%-0.16
22.50%-0.31
10.26%-0.35
334.21%0.89
-4.88%-0.43
Diluted earnings per share
-637.50%-1.18
0.00%-0.31
11.43%-0.31
-132.18%-0.28
34.88%-0.28
89.94%-0.16
22.50%-0.31
10.26%-0.35
328.95%0.87
-4.88%-0.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 000002,752.05%80M008,990.91%80M0
Operating revenue --0--0--0--0--02,752.05%80M--0--08,990.91%80M--0
Cost of revenue
Gross profit
Operating expense -15.09%84.77M16.80%22.69M-5.22%21.86M-27.97%19.82M-31.61%20.4M-12.02%99.83M-32.69%19.43M-18.21%23.06M-2.36%27.51M5.66%29.83M
Selling and administrative expenses -21.35%28.67M-5.69%7.28M-10.23%7.56M-33.37%6.83M-30.43%7M-12.53%36.45M-21.78%7.72M-15.43%8.42M-0.74%10.25M-12.66%10.06M
-General and administrative expense -21.35%28.67M-5.69%7.28M-10.23%7.56M-33.37%6.83M-30.43%7M-12.53%36.45M-21.78%7.72M-15.43%8.42M-0.74%10.25M-12.66%10.06M
Research and development costs -11.49%56.1M31.61%15.42M-2.34%14.3M-24.76%12.99M-32.21%13.4M-11.72%63.39M-38.35%11.71M-19.73%14.64M-3.29%17.26M18.29%19.77M
Operating profit -327.39%-84.77M-16.80%-22.69M5.22%-21.86M-137.75%-19.82M31.61%-20.4M82.08%-19.83M30.59%-19.43M15.95%-23.06M292.33%52.49M-6.78%-29.83M
Net non-operating interest income expense
Other net income (expense) -2.18%9.89M-17.55%2.36M65.54%2.26M-13.64%2.52M-7.29%2.75M-24.16%10.11M-11.59%2.86M-60.06%1.37M-16.87%2.92M-6.23%2.96M
Special income (charges) --0--0--0-----------2.06M--0---2.06M--------
-Less：Restructuring and merger&acquisition --0--0--0----------2.06M--0--2.06M--------
Other non- operating income (expenses) -18.76%9.89M-17.55%2.36M-34.02%2.26M-13.64%2.52M-7.29%2.75M-8.68%12.17M-11.59%2.86M0.20%3.43M-16.87%2.92M-6.23%2.96M
Income before tax -669.97%-74.88M-22.73%-20.33M9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M
Income tax
Net income -669.97%-74.88M-22.73%-20.33M9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M
Net income continuous Operations -669.97%-74.88M-22.73%-20.33M9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M
Minority interest income
Net income attributable to the parent company -669.97%-74.88M-22.73%-20.33M9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -669.97%-74.88M-22.73%-20.33M9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M
Basic earnings per share -637.50%-1.180.00%-0.3111.43%-0.31-131.46%-0.2834.88%-0.2889.94%-0.1622.50%-0.3110.26%-0.35334.21%0.89-4.88%-0.43
Diluted earnings per share -637.50%-1.180.00%-0.3111.43%-0.31-132.18%-0.2834.88%-0.2889.94%-0.1622.50%-0.3110.26%-0.35328.95%0.87-4.88%-0.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.68%
Sample Name
Sample Code
 +16.26%
Sample Name
Sample Code
 +13.08%
4
United Sts Brent Oil Fd Lp Unit
BNO
+10.72%
5
ProShares Ultra Energy
DIG
+9.35%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.90%
Sample Name
Sample Code
 +14.44%
Sample Name
Sample Code
 +13.72%
4
ASE Technology
ASX
+11.35%
5
Kingsoft Cloud
KC
+9.51%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -